Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-017590
Filing Date
2025-06-16
Accepted
2025-06-16 19:23:31
Documents
1
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 5365
  Complete submission text file 0001127602-25-017590.txt   6814
Mailing Address C/O XENCOR, INC. 465 N. HALSTEAD ST., SUITE 200 PASADENA CA 91107
Business Address
SIMPSON TODD E (Reporting) CIK: 0001216477 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36182 | Film No.: 251051496

Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Issuer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)